Jennifer Roberts, MD
Dermatology · Norman, OKNPI 1871799619
Payments from drug & device makers
Across 522 payments — averaging $17.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$2K
- Lilly USA, LLC$1K
- Sanofi$768
- AbbVie$756
- Regeneron Healthcare Solutions, Inc.$714
- Novartis$684
- plus $4K from 26 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 96 | $1,604 |
| Lilly USA, LLC | 63 | $1,035 |
| Sanofi | 35 | $768 |
| AbbVie | 40 | $756 |
| Regeneron Healthcare Solutions, Inc. | 27 | $714 |
| Novartis | 54 | $684 |
| Sun Pharmaceutical Industries Inc. | 28 | $522 |
| Pfizer | 28 | $499 |
| LEO Pharma Inc. | 23 | $415 |
| E.r. Squibb & Sons, L.L.C. | 18 | $336 |
| Mayne Pharma Commercial LLC | 16 | $254 |
| Amgen | 12 | $231 |
| VYNE Pharmaceuticals Inc. | 14 | $205 |
| Almirall LLC | 9 | $166 |
| UCB, Inc. | 10 | $155 |
| Incyte Corporation | 7 | $130 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 7 | $126 |
| Galderma Laboratories, L.p. | 7 | $111 |
| Arcutis Biotherapeutics, Inc. | 5 | $74 |
| Bristol Myers Squibb | 4 | $67 |
| Dermavant Sciences, Inc. | 4 | $60 |
| Sandoz | 2 | $35 |
| Nabriva Therapeutics, PLC | 2 | $30 |
| Radius Health, Inc. | 1 | $27 |
| Biocon Biologics Inc | 1 | $27 |
| Dermira, Inc. | 2 | $23 |
| Mannkind Corporation | 1 | $21 |
| Organon | 2 | $18 |
| Fresenius Kabi USA, LLC | 1 | $17 |
| Krystal Biotech Inc | 1 | $15 |
| Biohaven Pharmaceuticals, Inc. | 1 | $12 |
| Prugen, Inc. Pharmaceuticals | 1 | $2 |
How this compares
$9,141 in reported general payments places this provider in the 70th percentile of 114 dermatology providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other dermatology in Norman
- Thomas UriceNorman$23K
- David DuncanNorman$12K
- Paul AtakpoNorman$6K
- Joshua WeingartnerNorman$5K
- Alison FischerTulsa$1.5M
- Jarad LevinOklahoma City$1.2M
- Yaohan LamOklahoma City$1.1M
- Thomas HallStillwater$633K
- George MonksTulsa$530K
- Raymond CornelisonChickasha$525K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.